GAMCO Investors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-53,091
Closed -$2.92M 952
2022
Q2
$2.92M Buy
+53,091
New +$2.79M 0.03% 408

Other funds holding SRRA

GAMCO Investors's SRRA Position: Q3 2022 in Review

GAMCO Investors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 53,091 shares — an estimated $2.92M sold.

GAMCO Investors first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $2.92M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • GAMCO Investors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • GAMCO Investors sold 53,091 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $2.92M.
  • GAMCO Investors first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • GAMCO Investors's Sierra Oncology, Inc. Common Stock position peaked at $2.92M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on GAMCO Investors's 13F filing for Q3 2022, filed 10 Nov 2022.